Eli Lilly and Co. (NYSE:LLY) stock is trading higher after the company released better-than-expected Q4 earnings and issued fiscal 2026 guidance.
Earnings Overview
Eli Lilly reported fourth-quarter adjusted earnings of $7.54 per share, beating the consensus of $6.67.
The company’s sales reached $19.3 billion, beating the consensus of $17.96 billion.
Sales jumped 43% year over year, driven by a 46% increase in volume, partially offset by a 5% decrease due to lower realized prices.
Gross profit increased 43% to $15.9 billion. Gross margin was 82.5%, an increase of 0.3 percentage points. The increase in gross margin percent was primarily driven by a favorable product mix and improved cost of production, partially offset by lower realized prices.